Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · IEX Real-Time Price · USD
71.44
-0.32 (-0.45%)
May 1, 2024, 3:25 PM EDT - Market open
PBH Revenue
Prestige Consumer Healthcare had revenue of $1.13B in the twelve months ending December 31, 2023, with 2.29% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $282.74M with 2.62% year-over-year growth. In the fiscal year ending March 31, 2023, Prestige Consumer Healthcare had annual revenue of $1.13B with 3.76% growth.
Revenue (ttm)
$1.13B
Revenue Growth
+2.29%
P/S Ratio
3.11
Revenue / Employee
$2,025,420
Employees
560
Market Cap
3.55B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 1.13B | 40.91M | 3.76% |
Mar 31, 2022 | 1.09B | 143.45M | 15.21% |
Mar 31, 2021 | 943.37M | -19.65M | -2.04% |
Mar 31, 2020 | 963.01M | -12.77M | -1.31% |
Mar 31, 2019 | 975.78M | -65.40M | -6.28% |
Mar 31, 2018 | 1.04B | 159.12M | 18.04% |
Mar 31, 2017 | 882.06M | 75.81M | 9.40% |
Mar 31, 2016 | 806.25M | 91.62M | 12.82% |
Mar 31, 2015 | 714.62M | 117.24M | 19.63% |
Mar 31, 2014 | 597.38M | -22.74M | -3.67% |
Mar 31, 2013 | 620.12M | 179.03M | 40.59% |
Mar 31, 2012 | 441.09M | 104.58M | 31.08% |
Mar 31, 2011 | 336.51M | 43.91M | 15.01% |
Mar 31, 2010 | 292.60M | -1.74M | -0.59% |
Mar 31, 2009 | 294.35M | -20.76M | -6.59% |
Mar 31, 2008 | 315.11M | -3.53M | -1.11% |
Mar 31, 2007 | 318.63M | 21.97M | 7.40% |
Mar 31, 2006 | 296.67M | 7.60M | 2.63% |
Mar 31, 2005 | 289.07M | 217.34M | 302.97% |
Mar 31, 2003 | 71.73M | 25.53M | 55.27% |
Mar 31, 2002 | 46.20M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.66B |
Oscar Health | 5.86B |
PACS Group | 3.11B |
Envista Holdings | 2.57B |
Integer Holdings | 1.63B |
RadNet | 1.62B |
Ultragenyx Pharmaceutical | 434.25M |
Axsome Therapeutics | 270.60M |
PBH News
- 6 days ago - Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results - GlobeNewsWire
- 4 weeks ago - Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag - GlobeNewsWire
- 2 months ago - Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results - GlobeNewsWire
- 3 months ago - Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene - GlobeNewsWire
- 3 months ago - Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results - GlobeNewsWire
- 4 months ago - Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene - GlobeNewsWire
- 5 months ago - Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of Benzene - GlobeNewsWire
- 6 months ago - Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results - GlobeNewsWire